Clover Health Investments Other Current Liabilities 2020-2025 | CLOV

Clover Health Investments other current liabilities from 2020 to 2025. Other current liabilities can be defined as field containing the sum of all current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Clover Health Investments Annual Other Current Liabilities
(Millions of US $)
2024 $160
2023 $143
2022 $224
2021 $326
2020 $104
2019 $0
Clover Health Investments Quarterly Other Current Liabilities
(Millions of US $)
2025-03-31 $155
2024-12-31 $160
2024-09-30 $167
2024-06-30 $200
2024-03-31 $240
2023-12-31 $143
2023-09-30 $372
2023-06-30 $561
2023-03-31 $762
2022-12-31 $224
2022-09-30 $973
2022-06-30 $1,552
2022-03-31 $2,111
2021-12-31 $326
2021-09-30 $189
2021-06-30 $160
2021-03-31 $118
2020-12-31 $104
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.565B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.594B 60.55
Hims & Hers Health (HIMS) United States $12.830B 133.30
Doximity (DOCS) United States $11.392B 52.74
Tempus AI (TEM) United States $10.965B 0.00
IRhythm Technologies (IRTC) United States $4.223B 0.00
Inspire Medical Systems (INSP) United States $3.794B 59.28
Hinge Health (HNGE) United States $3.587B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.691B 0.00
Schrodinger (SDGR) United States $1.650B 0.00
Phreesia (PHR) United States $1.610B 0.00
Azenta (AZTA) United States $1.555B 72.25
Enovis (ENOV) United States $1.551B 8.65
Omnicell (OMCL) United States $1.318B 23.25
Evolent Health (EVH) United States $1.098B 93.50
Claritev (CTEV) United States $0.686B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Standard BioTools (LAB) United States $0.558B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Butterfly Network (BFLY) United States $0.514B 0.00
Talkspace (TALK) United States $0.422B 126.00
TruBridge (TBRG) United States $0.349B 775.00
Outset Medical (OM) United States $0.312B 0.00
Health Catalyst (HCAT) United States $0.268B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.241B 0.00
CapsoVision (CV) United States $0.198B 0.00
Zepp Health (ZEPP) Netherlands $0.165B 0.00
KORU Medical Systems (KRMD) United States $0.162B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.106B 0.00
CareCloud (CCLD) United States $0.100B 3.82
Insight Molecular Diagnostics (IMDX) United States $0.085B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.022B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00